Literature DB >> 29880100

Combined Transradial and Transpedal Approach for Femoral Artery Interventions.

Zoltán Ruzsa1, Robert Bellavics2, Balázs Nemes3, Artúr Hüttl3, András Nyerges3, Péter Sótonyi3, Olivier Francois Bertrand4, Kálmán Hüttl3, Béla Merkely3.   

Abstract

OBJECTIVES: The purpose of this prospective study was to evaluate the acute success and complication rates of combined transradial and transpedal access for femoral artery intervention.
BACKGROUND: Improved equipment and techniques have resulted in transition from transfemoral to transradial access for intervention of superficial femoral artery.
METHODS: Between 2014 and 2016, clinical and angiographic data from 145 consecutive patients with symptomatic superficial femoral stenosis, treated via primary radial access using the 6-F SheathLess Eaucath PV guiding catheter were evaluated in a pilot study. Secondary access was achieved through the pedal or popliteal artery. The primary endpoints were major adverse events, target lesion revascularization, and rates of major and minor access-site complications. Secondary endpoints included angiographic outcome, procedural factors, crossover rate to femoral access site, and duration of hospitalization.
RESULTS: Technical success was achieved in 138 patients (95.2%). Combined radial and pedal access was obtained in 22 patients (15.1%). The crossover rate to a femoral access site was 2%. Stent implantation was necessary in 23.4% of patients. Chronic total occlusion recanalization was performed in 63 patients, with a 90.4% technical success rate. The mean contrast consumption, radiation dose, and procedure time were 112.9 ml (101.8 to 123.9 ml), 21.84 Gy/cm2 (9.95 to 33.72 Gy/cm2), and 34.9 min (31.02 to 38.77 min), respectively. The cumulative rate of access-site complications was 4.8% (0% major, 4.8% minor). The cumulative incidence rates of major adverse events at 3 and 12 months follow-up was 8.3% and 19.2%. The cumulative incidence rates of death at 3- and 12-month follow-up were 2.8% and 5.6%.
CONCLUSIONS: Femoral artery intervention can be safely and effectively performed using radial and pedal access with acceptable morbidity and a high technical success rate.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  femoral artery angioplasty; femoral artery stenting; transpedal approach; transradial approach

Mesh:

Year:  2018        PMID: 29880100     DOI: 10.1016/j.jcin.2018.03.038

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  6 in total

Review 1.  Radial Access for Lower Extremity Peripheral Arterial Interventions: Do We Have the Tools?

Authors:  Raghuram Posham; Lindsay B Young; Robert A Lookstein; Constantino Pena; Rahul S Patel; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

Review 2.  [Innovations in the endovascular treatment of peripheral arterial disease].

Authors:  Jörg Teßarek; Alexander Oberhuber
Journal:  Gefasschirurgie       Date:  2021-08-13

3.  Usefulness of transpedal intervention for inferior epigastric artery bleeding following catheter ablation: a case report.

Authors:  Hirofumi Kusumoto; Kasumi Ishibuchi; Shin Takiuchi; Satoru Otsuji
Journal:  Eur Heart J Case Rep       Date:  2022-04-26

4.  Treatment of an external iliac artery chronic total occlusion using alternate access sites.

Authors:  Justin Ratcliffe; Mike Gorenchtein; Pankaj Khullar; Abel Casso Dominguez; Mohan Satish; Philip Green; Joseph Puma
Journal:  CVIR Endovasc       Date:  2019-12-13

Review 5.  Synthesis of Prussian Blue Nanoparticles and Their Antibacterial, Antiinflammation and Antitumor Applications.

Authors:  Danyang Li; Meng Liu; Wenyao Li; Qiang Fu; Liyang Wang; Enping Lai; Weixin Zhao; Kaile Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-21

6.  Distal Radial Artery Access for Superficial Femoral Artery Interventions.

Authors:  Zoltán Ruzsa; Ádám Csavajda; Balázs Nemes; Mónika Deák; Péter Sótonyi; Olivier F Bertrand; Béla Merkely
Journal:  J Endovasc Ther       Date:  2020-10-12       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.